
Company Legal Name
Latest Valuation
Founded Year
Headquarters
Loyal Health Inc. is a San Francisco-based biotech company developing pharmaceutical interventions to extend the lifespan and healthspan of dogs. Founded in 2019, the company represents a pioneering approach to companion animal longevity, addressing the significant market opportunity in pet healthcare where owners increasingly seek advanced medical solutions for their animals. Loyal's research focuses on developing FDA-approved drugs specifically designed to target aging mechanisms in canines, potentially revolutionizing veterinary medicine. The company operates at the intersection of longevity science and veterinary therapeutics, positioning itself as a first-mover in the emerging field of companion animal anti-aging treatments and lifespan extension.

Availability of information and platform features may vary by region and applicable requirements.
Eligibility and access may depend on user location, verification status, and applicable legal or regulatory requirements.
Additional platform details may be available after account creation, where applicable.
Identity, compliance, and other review steps may be required before access to certain materials or features.
Platform details, if applicable, should be reviewed in account materials before making any decision.
Any economic terms, if applicable, should be reviewed carefully in the relevant materials.

Private market interests may be illiquid, restricted, or difficult to transfer. Users should not assume that any secondary market will be available.
Valuations may reflect past financing rounds or other available information and may not represent a price at which any person can transact.
Company and sector risks may vary by business model, technology development, competition, regulation, and market conditions.
Operational, documentation, custody, or verification processes may involve limitations, delays, or dependencies.
Regulatory, tax, and legal requirements may change and may affect information availability, platform features, or user eligibility.


